Showing 1–12 of 12 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Chaisson R
…tion tuberculosis in individuals infected with both HIV and latent (inactive) Mycobacterium tuberculosis. Current guidelines from the American Thoracic Society and the Centers for Disease Control recommend 6 to 12 months of INH for PPD (purified protein derivative)-positive indi…
Stefania Cheli
…d prevent the occurrence of DILI and develop more effective treatments. Tuberculosis (TB) is the world's second leading cause of death from a single infectious agent in 2022, after COVID-19. In 2022, TB disease was estimated to affect 10.6 million people, of whom 1.3 million die…
Andrea A Howard, MD
…, transferred out); TB (tuberculosis) screening results; TB treatment (yes/no); TB treatment outcomes (if applicable); and retention in HIV care. A measurement cohort of 500 HIV-infected patients initiating IPT on or after July 1, 2013 will be recruited from the 10 clinics (n=25…
Sashi N Nair, Indira Brar, Gireeshkumar K.P.
…cribed in HIV infected patients. Developed countries, where guidelines on the treatment of PJP have been created have dramatically lower rates of latent and active TB than developing countries. PJP may obscure the diagnosis or delay the treatment of TB. Furthermore, treatment of …
M Ameri, L Suarez, Layla Abdul Jabbar, M Koppikar
…lly, recently, concept of roles of nutrition in immunology, latent infections, a short presentation of TB. Further discussing current guidelines, covering topics such as BCG, treatments, role of fluoroquinolones and MDR. With an examination of the social aspect by reviewing the a…
Gordin F, Brown LS
…of tuberculosis in patients who are coinfected with HIV and latent Mycobacterium tuberculosis (MTb). Current guidelines recommend 6 to 12 months of treatment with INH for purified protein derivative (PPD)-positive individuals. Problems with this treatment include compliance, adv…
Worku Nigussa, MD
… clinical decision-making. Since its endorsement by the WHO guidelines in 2010, Xpert MTB/RIF (Cepheid, CA, USA), a molecular test that can detect mycobacterial DNA and genetic polymorphisms associated with rifampicin resistance, has entered into diagnostic workup in both high- a…
J P Le, N Gupta, O Ahmed, P Zafar, R Gul, et al.
…, diabetes, lymphopenia, or immunosuppression. ATS/IDSA/CDC guidelines emphasize that IGRAs and TSTs are not diagnostic for active TB—they do not distinguish latent infection from disease and should not exclude TB when suspicion remains high. The combination of epidemiologic risk…
Prashant Kumar, Akhilesh Kumar, Rahul Raj
…E, 72 publications underwent an examination adhering to the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). The comprehensive approach included diverse languages and study settings, providing a thorough understanding of TBI …
Jason R Andrews, MD
This trial is designed to determine whether modifying the dose of isoniazid for individuals according to their n-acetyltransferase 2 (NAT2) genotype could increase the probability of achieving equivalence of area-under-the-curve.
Mark Hatherill
…hat MTBVAC will provide improved protection, as individuals latently infected with live M.tuberculosis have an 80% lower chance of developing TB, and as MTBVAC contains most of the genes deleted from BCG and presents a wider collection of antigens to the host immune system. Precl…
Rina La Distia Nora, MD, PhD
…until now corticosteroids and cycloplegics are the mainstay treatment for uveitis. However, appropriate administration of anti-infective drugs is necessary in cases of infection. Inflammation in TB-associated uveitis is thought to be the result of the immune response that occurs …